Hypermarcas (OTCMKTS:HYPMY) Shares Shorted: Short Interest Up 390.0% in October

Hypermarcas (OTCMKTS:HYPMY) saw a significant increase in short interest in October. As of October 30th, there was short interest totaling 8,208 shares, an increase of 390.0% from the October 15th total of 1,675 shares. Based on an average daily trading volume, of 84,726 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are short sold.

Hypermarcas Trading Down 2.6%

Shares of OTCMKTS:HYPMY opened at $4.00 on Wednesday. The company has a market cap of $2.82 billion, a P/E ratio of 8.00 and a beta of 0.78. The stock’s 50-day moving average is $4.63 and its 200-day moving average is $4.41. Hypermarcas has a 52-week low of $3.39 and a 52-week high of $5.77. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.26 and a current ratio of 1.86.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group raised Hypermarcas to a “strong-buy” rating in a research report on Monday, July 20th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, Hypermarcas presently has a consensus rating of “Buy”.

Hypermarcas Company Profile

Hypermarcas was a Brazilian consumer-products and pharmaceutical company that later adopted the name Hypera Pharma. The company refocused its operations on pharmaceuticals after divesting a number of businesses in other consumer-goods categories. Today, Hypera Pharma develops, manufactures and markets medicines in Brazil, including prescription drugs, over-the-counter products and branded generics. Its portfolio also includes vitamins and supplements, and it sells products under brands such as Neo Química and Mantecorp.